Literature DB >> 15526330

Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 3: role of site-specific mutations.

Lucia Falcigno1, Romina Oliva, Gabriella D'Auria, Massimiliano Maletta, Monica Dettin, Antonella Pasquato, Carlo Di Bello, Livio Paolillo.   

Abstract

Proteolytic processing of HIV gp160 to produce gp120 and gp41 is performed by PC enzymes. This process is a prerequisite for the virus infectivity, since both gp120 and gp41 participate in the virus HIV-1 entry mechanism. The structure of the gp120/gp41 junction remains to be elucidated, and the structural features required for molecular recognition between HIV-1 gp160 and proteolytic enzymes have not been clarified. Furin is the best PC candidate for the gp160 proteolytic processing known to date. In previous studies on model peptides, we have shown the relevance of an N-terminal helix for the proper recognition of the gp160 processing site by furin. Here we analyze the effect of point mutations in peptides lacking a regular N-terminal helix. To this end, we present the structure-activity characterization of three peptide analogues of the HIV gp160 processing site that all present mutations in proline at positions P3 and/or P2', while sharing the same N-terminal sequence, containing helix-breaking D-amino acids. Conformational analysis of the peptides was carried out in solution by NMR techniques, and furin's efficiency in cleaving them was measured. Structural findings are presented and discussed in relation to the different exhibited activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526330     DOI: 10.1002/cbic.200400181

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  2 in total

1.  Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.

Authors:  Wendy M Blay; Theresa Kasprzyk; Lynda Misher; Barbra A Richardson; Nancy L Haigwood
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

2.  Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.

Authors:  Xingguang Li; Junjie Zai; Qiang Zhao; Qing Nie; Yi Li; Brian T Foley; Antoine Chaillon
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.